Item 8.01. Other Events.

On June 8, 2022, India Globalization Capital, Inc. (the "Company") distributed a press release announcing that the United States Patent and Trademark Office ("USPTO") issued a patent (#11,351,152) to the Company titled "Method and Composition for Treating Seizure Disorders."

The patent is assigned to IGC and relates to compositions and methods for treating multiple types of seizure disorders and epilepsy in humans and animals using a combination of the cannabinoid cannabidiol ("CBD") with other compounds.

The Company's press release announcing the new issued patent is included as Exhibit 99.1 to this report.

Cautionary Statement Regarding Forward Looking Statements:

This report contains forward-looking statements identified by the use of words such as should, believes, plans, goals, expects, may, will, or the negatives thereof, and other variations thereon or comparable terminology. Any forward-looking statements contained herein are based largely on IGC's expectations and are subject to several risks and uncertainties, certain of which are beyond IGC's control. Actual results could differ materially from these forward-looking statements as a result of, among other factors, the Company's failure or inability to commercialize one or more of the Company's products or technologies, including the product or formulation described in this release; or failure to obtain regulatory approval for the product or formulation described in this release; general economic conditions that are less favorable than expected, including as a result of the ongoing COVID-19 pandemic; the FDA's general position regarding cannabis- and hemp-based products; and other factors, many of which are discussed in IGC's SEC filings. IGC incorporates by reference the human trial disclosures and Risk Factors identified in its Annual Reports on Form 10-K filed with the SEC on June 14, 2021, and Quarterly Report on Form 10-Q, filed with the SEC on August 11, 2021, and October 29, 2021, as if fully incorporated and restated herein. In light of these risks and uncertainties, there can be no assurance that the forward-looking information contained in this release will occur. All forward-looking statements contained in this filing and press release speak only as of the date on which they were made. The Company undertakes no obligation to update such statements to reflect events that occur or circumstances that exist after the date on which they were made.

Item 9.01. Financial Statements and Exhibits.






(d) Exhibits



Exhibit No. Description



99.1          Press Release Dated June 8, 2022
104         Cover Page Interactive Data File (formatted as Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses